Search For "vaccine"
COVID-19 vaccine inequity 'catastrophic moral failure', says WHO
Updated : 5 years, 3 months ago IST
Geneva [Switzerland], March 23 (ANI/Xinhua): Michael Ryan, Executive Director of World Health Organisation (WHO) Health Emergencies Program, said on Monday that the "inequitable" COVID-19 vaccine distribution was a "catastrophic moral failure" and a "failed opportunity."
Read More
RDIF, Virchow Biotech ink deal to produce Sputnik V vaccine in India
Updated : 5 years, 3 months ago IST
Moscow [Russia], March 23 (ANI): The Russian Direct Investment Fund (RDIF) and Hyderabad-based Virchow Biotech Private Limited on Monday inked an agreement to produce up to 200 million doses per year of Sputnik V vaccine (Russian made) in India.
Read More
Haryana: 2.48 lakh beneficiaries administered COVID-19 vaccine doses on Mo
Updated : 5 years, 3 months ago IST
Chandigarh (Haryana) [India], March 23 (ANI): On its 'Mega Vaccination Day' against COVID-19, Haryana Health Department administered vaccine doses to 2,48,312 beneficiaries on Monday.
Read More
Over 800 COVID-19 cases in Delhi for 3rd day in row
Updated : 5 years, 3 months ago IST
New Delhi [India], March 22 (ANI): The national capital reported over 800 coronavirus cases for the third day on the trot on Monday while reporting 888 new infections and seven fatalities.
Read More
Over 4.72 crore coronavirus vaccine doses administered so far
Updated : 5 years, 3 months ago IST
New Delhi [India], March 22 (ANI): The cumulative number of COVID-19 vaccine doses administered in the country has crossed 4.72 crore with 19,65,635 doses being given on Monday, the Union Health Ministry said.
Read More
France's Le Pen says government should consider using Sputnik V without EU
Updated : 5 years, 3 months ago IST
Paris [France], March 22 (ANI/Sputnik): Marine Le Pen, the leader of the right-wing National Rally party on Monday said that France should pursue the use of vaccines against the coronavirus, unauthorized by the European Union, including Russia's Sputnik V, without waiting for the relevant ap
Read More
Increase interval between two doses of Covishield to 4-8 weeks: Centres to
Updated : 5 years, 3 months ago IST
New Delhi [India], March 22 (ANI): In view of the emerging scientific evidence, the interval between two doses of a specific COVID-19 vaccine that is Covishield, has been revisited by the National Technical Advisory Group on Immunisation (NTAGI) and subsequently by National Expert Group on V
Read More
India now famous for helping world, says Iranian envoy Chegani on vaccine
Updated : 5 years, 3 months ago IST
New Delhi [India], March 22 (ANI): Lauding the efforts by India to provide Covid-19 vaccines to other countries, Iran's ambassador to India Dr Ali Chegeni on Monday said that India is "now famous" in helping all the countries in the world.
Read More
AstraZeneca plans to apply for US emergency nod for Covid-19 jab in April
Updated : 5 years, 3 months ago IST
Cambridge [UK], March 22 (ANI): AstraZeneca said on Monday that the company plans to apply for emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine in the first half of April.
Read More
Bhutan PM thanks PM Modi for additional 400,000 doses of COVID-19 vaccine
Updated : 5 years, 3 months ago IST
Thimphu [Bhutan], March 22 (ANI): Bhutan Prime Minister Lotay Tshering on Monday said that the country had received additional 400,000 doses of Covishield vaccine from India, making possible the nationwide rollout of the vaccination programme against COVID-19.
Read More
BJP leader Murli Manohar Joshi takes first shot of COVID-19 vaccine at AII
Updated : 5 years, 3 months ago IST
New Delhi [India], March 22 (ANI): Senior Bharatiya Janata Party (BJP) leader Murli Manohar Joshi administered his first dose of COVID-19 vaccine on Monday.
Read More
AstraZeneca vaccine is 79 pct effective against symptomatic Covid-19, says
Updated : 5 years, 3 months ago IST
Washington [US] March 22 (ANI): AstraZeneca's Covid-19 vaccine showed 79 per cent efficacy against symptomatic disease and 100 per cent efficacy against severe disease and hospitalisation in a new, US-based clinical trial, the company said Monday.
Read More